Effect of propranolol on secretin-induced gastrin release and secretin-induced tachycardia in patients with the Zollinger-Ellison syndrome

Alimentary Pharmacology & Therapeutics
M GoldschmeidtM Feldman

Abstract

The mechanism for secretin-induced gastrin release in the Zollinger-Ellison syndrome is uncertain. We evaluated whether the stimulatory effect of intravenous secretin on gastrin release was partly mediated through a beta-adrenergic stimulatory mechanism. Serum gastrin concentrations and heart rate were monitored in six patients with the Zollinger-Ellison syndrome. Secretin (2 clinical units/kg) increased mean serum gastrin concentrations from 1558 pg/ml basally to a peak of 3683 pg/ml (136% above baseline). This increase was not altered by pretreatment with 2 mg of propranolol intravenously, a dose which in previous studies blocked terbutaline-induced gastrin release. Secretin increased heart rate by 14 beats/min (20% above base-line) and this also was not altered by propranolol pretreatment. Thus, the stimulatory effects of secretin on gastrinoma cells and the heart do not appear to be mediated by beta-adrenergic receptors.

References

Jan 1, 1978·Scandinavian Journal of Gastroenterology·J G StageO B Muckadell
Dec 1, 1977·Annals of Internal Medicine·C W DeveneyL W Way
Sep 1, 1976·The Journal of Clinical Investigation·C T RichardsonJ S Fordtran
Nov 1, 1985·Journal of Cardiovascular Pharmacology·P GunnesR Jorde
Apr 15, 1972·Lancet·J R HayesK D Buchanan
Dec 1, 1974·Annals of Internal Medicine·B E KoltsJ E McGuigan
Sep 1, 1972·Annals of Surgery·J C ThompsonE N Brandt
Apr 1, 1970·The American Journal of Physiology·G Ross
Feb 1, 1980·The Journal of Clinical Endocrinology and Metabolism·Y SeinoH Imura
Dec 1, 1982·Digestive Diseases and Sciences·M ImamuraT Tobe
Aug 1, 1981·Regulatory Peptides·W LondongA Schwanner
Sep 1, 1981·Journal of Clinical Gastroenterology·C B Lamers
Dec 1, 1980·Digestive Diseases and Sciences·M FeldmanC T Richardson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.